Filing Details

Accession Number:
0001384101-19-000016
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-28 16:52:15
Reporting Period:
2019-02-26
Accepted Time:
2019-02-28 16:52:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1384101 Veracyte Inc. VCYT Services-Medical Laboratories (8071) 205455398
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1588970 H Bonnie Anderson 6000 Shoreline Court
Suite 300
South San Francisco CA 94080
Chairman And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-26 20,000 $2.68 96,541 No 4 M Direct
Common Stock Disposition 2019-02-26 15,300 $20.74 81,241 No 4 S Direct
Common Stock Disposition 2019-02-26 4,700 $21.58 76,541 No 4 S Direct
Common Stock Acquisiton 2019-02-28 30,000 $0.00 106,541 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2019-02-26 20,000 $0.00 20,000 $2.68
Common Stock Stock Option (right to buy) Acquisiton 2019-02-28 225,000 $0.00 225,000 $20.21
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
46,500 2022-03-09 No 4 M Direct
225,000 2029-02-27 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 99,085 Indirect The Bonnie H. Anderson Living Trust
Footnotes
  1. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018.
  2. Represents weighted average sales price. Sale prices for the transactions range from $20.48 to $21.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  3. Represents weighted average sales price. Sale prices for the transactions range from $21.54 to $21.63. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  4. Restricted stock units awarded on February 28, 2019 vest 25% on March 2, 2020 and 1/16 per quarter thereafter, based on continuing service on each vesting date.
  5. The option is fully vested.
  6. The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.